Phenolics from Garcinia mangostana inhibit Advanced Glycation Endproducts formation: Effect on Amadori products, cross-linked structures and protein thiols

Molecules

Volumn 21, Issue 2, 2016, Pages

  Abdallah, Hossam M ^a,b   El Bassossy, Hany ^a,c   Mohamed, Gamal A ^a,d   El Halawany, Ali M ^a,b   Alshali, Khalid Z ^e   Banjar, Zainy M ^e  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

^c Zagazig University   (Egypt)

^d Al Azhar University   (Egypt)

^e Aziz University   (Saudi Arabia)

Author keywords

Advanced glycation endproducts; Amadori product; Aromadendrin; Benzophenone; Epicatechin; Garcimangosone D; Mangosteen

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AROMADEDRIN; BENZOPHENONE; BENZOPHENONE DERIVATIVE; BOVINE SERUM ALBUMIN; CATECHIN; FLAVONOID; GARCIMANGOSONE D; GLUCOSE; GLUCOSIDE; PLANT EXTRACT; THIOL DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; CHEMISTRY; GARCINIA MANGOSTANA; ISOLATION AND PURIFICATION; PROTEIN AGGREGATION, PATHOLOGICAL;

ANIMALS; BENZOPHENONES; CATECHIN; CATTLE; FLAVONOIDS; GARCINIA MANGOSTANA; GLUCOSE; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; PLANT EXTRACTS; PROTEIN AGGREGATION, PATHOLOGICAL; SERUM ALBUMIN, BOVINE; SULFHYDRYL COMPOUNDS;

EID: 84963642498     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21020251     Document Type: Article

References (53)

1. Negre-Salvayre, A.; Salvayre, R.; Augé, N.; Pamplona, R.; Portero-Otin, M. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox Signal. 2009, 11, 3071-3109. [CrossRef] [PubMed]
2. Singh, V.P.; Bali, A.; Singh, N.; Jaggi, A.S. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 2014, 18, 1-14. [CrossRef] [PubMed]
3. Vitek, M.P.; Bhattacharya, K.; Glendening, J.M.; Stopa, E.; Vlassara, H.; Bucala, R.; Manogue, K.; Cerami, A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 1994, 91, 4766-4770. [CrossRef] [PubMed]
4. Schmidt, A.M.; Stern, D. Atherosclerosis and diabetes: The RAGE connection. Curr. Atheroscler. Rep. 2000, 2, 430-436. [CrossRef] [PubMed]
5. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46, 223-234. [CrossRef] [PubMed]
6. Ahmed, N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67, 3-21. [CrossRef] [PubMed]
7. Wu, C.H.; Huang, S.M.; Lin, J.A.; Yen, G.C. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011, 2, 224-234. [CrossRef] [PubMed]
8. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44, 129-146. [CrossRef] [PubMed]
9. Gleissner, C.A.; Galkina, E.; Nadler, J.L.; Ley, K. Mechanisms by which diabetes increases cardiovascular disease. Drug Discov. Today Dis. Mech. 2007, 4, 131-140. [CrossRef] [PubMed]
10. Magadula, J.J.; Mbwambo, Z.H.; Gatto, J.; Derbré, S.; Guilet, D.; Richomme, P. Polyphenolic compounds with anti-AGEs activity from three Clusiaceae plants. Eur. J. Med. Plants 2014, 4, 1336-1344. [CrossRef]
11. Okada, Y.; Okada, M. Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells. J. Pharm. Bioallied Sci. 2015, 7, 145-150. [CrossRef] [PubMed]
12. Wu, Q.; Li, S.; Li, X.; Sui, Y.; Yang, Y.; Dong, L.; Xie, B.; Sun, Z. Inhibition of advanced glycation endproduct formation by lotus seedpod oligomeric procyanidins through RAGE-MAPK signaling and NF-κB activation in high-fat-diet rats. J. Agric. Food Chem. 2015, 63, 6989-6998. [CrossRef] [PubMed]
13. Sompong, W.; Adisakwattana, S. Inhibitory effect of herbal medicines and their trapping abilities against methylglyoxal-derived advanced glycation end-products. BMC Complement. Altern. Med. 2015, 15, 1. [CrossRef]
14. Peng, X.; Zheng, Z.; Cheng, K.W.; Shan, F.; Ren, G.X.; Chen, F.; Wang, M. Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts. Food Chem. 2008, 106, 475-481. [CrossRef]
15. Ryu, H.W.; Cho, J.K.; Curtis-Long, M.J.; Yuk, H.J.; Kim, Y.S.; Jung, S.; Kim, Y.S.; Lee, B.W.; Park, K.H. α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry 2011, 72, 2148-2154. [CrossRef] [PubMed]
16. Abdallah, H.; El-Bassossy, H.; El-Halawany, A.; Mohamed, G.; Alshali, K.; Banjar, Z. PP. 14.02: Psiadia punctulata and Garcinia mangostana have potent vasorelaxant activity on isolated rat aorta. J. Hypertens. 2015, 33, e246. [CrossRef]
17. Ohno, R.I.; Moroishi, N.; Sugawa, H.; Maejima, K.; Saigusa, M.; Yamanaka, M.; Nagai, M.; Yoshimura, M.; Amakura, Y.; Nagai, R. Mangosteen pericarp extract inhibits the formation of pentosidine and ameliorates skin elasticity. J. Clin. Biochem. Nutr. 2015, 57, 27-32. [CrossRef] [PubMed]
18. Obolskiy, D.; Pischel, I.; Siriwatanametanon, N.; Heinrich, M. Garcinia mangostana L.: A phytochemical and pharmacological review. Phytother. Res. 2009, 23, 1047-1065. [CrossRef] [PubMed]
19. Mohamed, G.A.; Ibrahim, S.R.; Shaaban, M.I.; Ross, S.A. Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia 2014, 98, 215-221. [CrossRef] [PubMed]
20. Booth, A.A.; Khalifah, R.G.; Todd, P.; Hudson, B.G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs) novel inhibition of post-Amadori glycation pathways. J. Biol. Chem. 1997, 272, 5430-5437. [CrossRef] [PubMed]
21. Monnier, V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol. 1990, 45, B105-B111. [CrossRef] [PubMed]
22. Wei, Y.; Chen, L.; Chen, J.; Ge, L.; He, R.Q. Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC Cell Biol. 2009, 10, 10. [CrossRef] [PubMed]
23. Huang, Y.L.; Chen, C.C.; Chen, Y.J.; Huang, R.L.; Shieh, B.J. Three xanthones and a benzophenone from Garcinia mangostana. J. Nat. Prod. 2001, 64, 903-906. [CrossRef] [PubMed]
24. Sawi, S.E. A new rare 8-C-glucosylflavonoid and other eight flavonoids from the molluscicidal plant Acacia saligna Wendl. Pharm. Pharmacol. Lett. 2001, 11, 30-33.
25. Mabry, T.; Markham, K.; Thomas, M. The Systematic Identification of Flavonoids; Springer-Verlag: New York, NY, USA, 1970; pp. 274-343.
26. Jiang, H.Z.; Quan, X.F.; Tian, W.X.; Hu, J.M.; Wang, P.C.; Huang, S.Z.; Cheng, Z.Q.; Liang, W.J.; Zhou, J.; Ma, X.F. Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana. Bioorg. Med. Chem. Lett. 2010, 20, 6045-6047. [CrossRef] [PubMed]
27. Forbes-Hernández, T.Y.; Giampieri, F.; Gasparrini, M.; Mazzoni, L.; Quiles, J.L.; Alvarez-Suarez, J.M.; Battino, M. The effects of bioactive compounds from plant foods on mitochondrial function: A focus on apoptotic mechanisms. Food Chem. Toxicol. 2014, 68, 154-182. [CrossRef] [PubMed]
28. Wu, C.H.; Yen, G.C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 2005, 53, 3167-3173. [CrossRef] [PubMed]
29. Kim, J.; Kim, C.S.; Moon, M.K.; Kim, J.S. Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products. Eur. J. Pharmacol. 2015, 748, 108-114. [CrossRef] [PubMed]
30. Jeon, Y.E.; Yin, X.F.; Choi, D.B.; Lim, S.S.; Kang, I.J.; Shim, J.H. Inhibitory activity of aromadendrin from prickly pear (Opuntia ficus-indica) root on aldose reductase and the formation of advanced glycation end products. Food Sci. Biotechnol. 2011, 20, 1283-1288. [CrossRef]
31. Yamaguchi, F.; Ariga, T.; Yoshimura, Y.; Nakazawa, H. Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind. J. Agric. Food Chem. 2000, 48, 180-185. [CrossRef] [PubMed]
32. Morimitsu, Y.; Yoshida, K.; Esaki, S.; Hirota, A. Protein glycation inhibitors from thyme (Thymus vulgaris). Biosci. Biotechnol. Biochem. 1995, 59, 2018-2021. [CrossRef] [PubMed]
33. Bouma, B.; Kroon-Batenburg, L.M.; Wu, Y.P.; Brünjes, B.; Posthuma, G.; Kranenburg, O.; de Groot, P.G.; Voest, E.E.; Gebbink, M.F. Glycation induces formation of amyloid cross-β structure in albumin. J. Biol. Chem. 2003, 278, 41810-41819. [CrossRef] [PubMed]
34. Luthra, M.; Balasubramanian, D. Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J. Biol. Chem. 1993, 268, 18119-18127. [PubMed]
35. Tokuyama, T.; Yagui, K.; Yamaguchi, T.; Huang, C.I.; Kuramoto, N.; Shimada, F.; Miyazaki, J.I.; Horie, H.; Saito, Y.; Makino, H. Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic β cells. Metabolism 1997, 46, 1044-1051. [CrossRef]
36. Marzban, L.; Verchere, C. The role of islet amyloid polypeptide in type 2 diabetes. Can. J. Diabetes 2004, 28, 39-47.
37. Zeng, J.; Davies, M.J. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Chem. Res. Toxicol. 2006, 19, 1668-1676. [CrossRef] [PubMed]
38. Aćimović, J.M.; Stanimirović, B.D.; Mandić, L.M. The role of the thiol group in protein modification with methylglyoxal. J. Serb. Chem. Soc. 2009, 74, 867-883. [CrossRef]
39. Dalle-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9, 169-176. [CrossRef]
40. Dalle-Donne, I.; Rossi, R.; Giustarini, D.; Milzani, A.; Colombo, R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23-38. [CrossRef]
41. Carubelli, R.; Schneider, J.E.; Pye, Q.N.; Floyd, R.A. Cytotoxic effects of autoxidative glycation. Free Radic. Biol. Med. 1995, 18, 265-269. [CrossRef]
42. Smith, P.R.; Thornalley, P.J. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Eur. J. Biochem. 1992, 210, 729-739. [CrossRef] [PubMed]
43. Nagai, R.; Ikeda, K.; Higashi, T.; Sano, H.; Jinnouchi, Y.; Araki, T.; Horiuchi, S. Hydroxyl radical mediates N″-(carboxymethyl)lysine formation from Amadori product. Biochem. Biophys. Res. Commun. 1997, 234, 167-172. [CrossRef] [PubMed]
44. Graf, E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992, 13, 435-448. [CrossRef]
45. Ogiwara, T.; Satoh, K.; Kadoma, Y.; Murakami, Y.; Unten, S.; Atsumi, T.; Sakagami, H.; Fujisawa, S. Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res. 2001, 22, 2711-2717.
46. Peyroux, J.; Sternberg, M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. 2006, 54, 405-419. [CrossRef] [PubMed]
47. Adisakwattana, S.; Jiphimai, P.; Prutanopajai, P.; Chanathong, B.; Sapwarobol, S.; Ariyapitipan, T. Evaluation of α-glucosidase, α-amylase and protein glycation inhibitory activities of edible plants. Int. J. Food Sci. Nutr. 2010, 61, 295-305. [CrossRef] [PubMed]
48. Ghareib, S.A.; El-Bassossy, H.M.; Elberry, A.A.; Azhar, A.; Watson, M.L.; Banjar, Z.M. 6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation. Drug Des. Dev. Ther. 2015, 9, 6019-6026.
49. El-Bassossy, H.M.; Abo-Warda, S.M.; Fahmy, A. Rosiglitazone, a peroxisome proliferator-activated receptor gamma stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin. Exp. Pharmacol. Physiol. 2012, 39, 643-649. [CrossRef] [PubMed]
50. El-Bassossy, H.M.; Abo-Warda, S.M.; Fahmy, A. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation. Phytother. Res. 2013, 27, 1678-1684. [CrossRef] [PubMed]
51. Johnson, R.N.; Metcalf, P.A.; Baker, J.R. Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 1983, 127, 87-95. [CrossRef]
52. LeVine, H., III. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309, 274-284. [PubMed]
53. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77. [CrossRef]